[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-353713-105":59,"doc-detail-353713-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","hpv18e6-and-cdk5-virus-host-interaction-is-a-prospective-therapeutic-target-for-hpv-positive-cervical-cancer","HPV18E6 and CDK5 virus-host interaction is a prospective therapeutic target for HPV-positive cervical cancer","","The E6 oncoprotein encoded by cancer-causing human papillomavirus (HPV) supports viral-driven cell proliferation and cancer progression. This study identifies cyclin-dependent kinase 5 (CDK5) as an E6-encoded host target and shows that E6–CDK5 interaction elevates E6 steady-state levels. Using pharmacological inhibition, gene silencing, molecular docking, and in vitro screening, CP681301 is found to block CDK5–E6 complex formation and suppress the E6-E6AP-p53 axis, reducing proliferation, transformation, migration, and Matrigel invasion of HPV-positive cells. The findings support CDK5-E6 as a promising next-generation therapeutic target for HPV-associated diseases.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/hpv18e6-and-cdk5-virus-host-interaction-is-a-prospective-therapeutic-target-for-hpv-positive-cervical-cancer/353713/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/hpv18e6-and-cdk5-virus-host-interaction-is-a-prospective-therapeutic-target-for-hpv-positive-cervical-cancer/353713.png","ImageObject",300,407,{"name":92,"@type":93},"Asher","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-19","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":44},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What host target does HPV E6 interact with, according to the study?","Question",{"text":112,"@type":113},"The study identifies cyclin-dependent kinase 5 (CDK5) as a previously unidentified host target of the HPV E6 oncoprotein.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How does CP681301 affect the CDK5–E6 complex and HPV-positive cancer cells?",{"text":117,"@type":113},"CP681301 blocks formation of the CDK5–E6 complex and inhibits the E6-E6AP-p53 axis, leading to reduced proliferation, transformation, migration, and Matrigel invasion of HPV-positive cells.",{"name":119,"@type":110,"acceptedAnswer":120},"Why is the CDK5–E6 interaction considered important for therapeutic development?",{"text":121,"@type":113},"Because the interaction increases E6 steady-state levels and, when CDK5-E6 binding is pharmacologically disrupted, cancer phenotypes of HPV-positive cells are suppressed, supporting CDK5-E6 as a drug target.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},353713,1790686534,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":44,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},687197207639,"https://ap-avatar.wpscdn.com/davatar_a8503ba1806abce46bf441b54a3ca4cd","Tumour Virus Research 21 (2026) 200339  \nContents lists available at ScienceDirect  \nTumour Virus Research  \njournal [homepage:](homepage: www.journals.elsevier.com/tumour-virus-research)[ www.journals.elsevier.com/tumour-virus-research](homepage: www.journals.elsevier.com/tumour-virus-research)  \n| HPV18E6 and CDK5 virus-host interaction is a prospective therapeutic target for HPV-positive cervical cancer\u003Cbr>Chuanyun Xiao a,b,1, Lixin Wang a,1, Chichao Xiaa, Paul Kay Sheung Chana, Siaw Shi Boona,*  a Department of Microbiology, The Chinese University of Hong Kong, Prince of Wales Hospital, Shatin, New Territories, Hong Kong Special Administrative Region of China\u003Cbr>b Key Laboratory of Modern Preparation of Traditional Chinese Medicine, Ministry of Education, Jiangxi University of Chinese Medicine, Nanchang, 330004, PR China |  |  |\n| --- | --- | --- |\n| A R T I C L E I N F O |  | A B S T R A C T |\n| Keywords: Cervical cancer E6\u003Cbr>CDK5\u003Cbr>Protein-protein interaction CP681301\u003Cbr>HPV-Mediated carcinogenesis |  | The E6 oncoprotein encoded by the cancer-causing human papillomavirus (HPV) is vital for maintaining the ability of the virus to promote cell proliferation and cancer progression. This study identified that cyclindependent kinase 5 (CDK5) is a previously unidentified host target of E6 encoded by cancer-causing HPV genotypes. Although E6 may not be a phosphorylation substrate of CDK5, interaction with CDK5 nonetheless increases the steady-state level of E6. To further elucidate the significance of CDK5-E6 interaction, we adopted pharmacological inhibition and silencing approaches. Leveraging the computer-aided molecular docking and in vitro screening approaches, we identified CP681301, a potent CDK5 inhibitor, which can inhibit CDK5-E6 complex formation. More intriguingly, this study underlines that CP681301 can inhibit the E6-E6AP-p53 axis, conferring inhibition on cancer phenotypes of HPV-positive cancer cells, including the ability of cells to proliferate, transform, migrate and invade through Matrigel. Our study highlights that CDK5-E6 is a promising drug target for the design of next-generation targeted therapeutics for HPV-associated diseases. |\n\n1. Introduction  \nCervical cancer is the fourth most common cancer in women, mainly caused by persistent infection by the cancer-causing types of human papillomavirus (HPV) [1,2]. Even though cervical cancer can be effectively prevented through regular screening and early surgical interventions, the overall burden of the disease, especially in Low- and Middle-Income Countries (LMICs), has not decreased significantly [3–5]. Moreover, the implementation of national HPV vaccination programs in most places remains non-gender neutral. In LMICs, due to a lack of established infrastructure and financial support [6,7], some of them may rely on support from non-profit organizations, like the World Health Organisation (WHO) and Gavi (the Vaccine Alliance) ([https://](https://)[ ](https://)[pubmed.ncbi.nlm.nih.gov/32706907/](pubmed.ncbi.nlm.nih.gov/32706907/)). Among over 400 HPV genotypes identified, 13 are classified as the so-called high-risk types. HPV16 and 18 are the most prevalent types contributing to over 70% of invasive cervical cancers [4]. In case of low-grade lesions, full viral genome expression can be detected in the uterine cervix. As the lesion develops, the HPV genome can integrate into the host cells, resulting in the continuous overexpression of the E6 and E7 oncoproteins [8] and loss of  \nother viral early genes. The oncogenic properties of E6 and E7 are well described by their ability to degrade host tumour suppressors. E6 interacts and degrades the tumour suppressor protein p53 through the ubiquitin-proteasome pathway. The interaction between E6 and p53 is mediated by the formation of a complex involving cellular proteins, such as E6-associated protein (E6AP) and Mouse Double Minute 2 homolog (MDM2). E6 recruits E6AP, which acts as an E3 ubiquitin ligase, leadi","cbCaieFrghcSEor0","https://ap.wps.com/l/cbCaieFrghcSEor0","pdf",8053627,14,"English","# Introduction\n## HPV and E6/E7 oncogenic mechanisms\n## CDKs and the role of CDK5","[{\"question\":\"What host target does HPV E6 interact with, according to the study?\",\"answer\":\"The study identifies cyclin-dependent kinase 5 (CDK5) as a previously unidentified host target of the HPV E6 oncoprotein.\"},{\"question\":\"How does CP681301 affect the CDK5–E6 complex and HPV-positive cancer cells?\",\"answer\":\"CP681301 blocks formation of the CDK5–E6 complex and inhibits the E6-E6AP-p53 axis, leading to reduced proliferation, transformation, migration, and Matrigel invasion of HPV-positive cells.\"},{\"question\":\"Why is the CDK5–E6 interaction considered important for therapeutic development?\",\"answer\":\"Because the interaction increases E6 steady-state levels and, when CDK5-E6 binding is pharmacologically disrupted, cancer phenotypes of HPV-positive cells are suppressed, supporting CDK5-E6 as a drug target.\"}]","HPV18E6 and CDK5 virus-host interaction is a prospective therapeutic target for HPV-positive cervical cancer | PDF",1790106909,35,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/0ad4b3d834f573a7597bc7afbe4582a1.webp",983,1310,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/c7f93bb3ebbe9d2cb8436dcbff5a0f8e.webp",982,1309,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/55f215562b74122c11dc5728acb4ec50.webp",981,1308,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/95476f61b5eb7764ed12c035307079a2.webp",980,1306]